Ceftizoxime For Injection Usp 250 Mg/1000 Mg /2gm

What is Ceftizoxime For Injection USP 250 Mg/1000 Mg /2gm?

Ceftizoxime For Injection USP is a cephalosporin antibiotic presented as a dry powder injection. Ceftizoxime is used in the treatment of certain bacterial infections when clinically indicated. The appropriate use depends on the suspected or confirmed bacterial pathogen, infection site, patient-specific factors and applicable prescribing information. Preparation and administration must follow the approved product instructions.

Uses / Indications

Ceftizoxime is a cephalosporin antibacterial agent used for certain susceptible bacterial infections. Its clinical application depends on the organism involved, infection severity and site, and relevant susceptibility results.

• Treatment of susceptible bacterial infections when indicated by the approved prescribing information.

• Selection based on clinical assessment and applicable antimicrobial guidelines.

The approved indications for this specific product should be confirmed against its authorised product information and local regulatory requirements. It is not intended to treat viral infections such as influenza or the common cold.

5. Benefits

• Contains ceftizoxime, an established cephalosporin antibacterial agent.

• Available in a dry powder injection presentation.

• Intended for use in appropriate clinical settings under professional supervision.

• Product strength options include 250 Mg, 1000 Mg and 2gm, as supplied.

• Pharmaceutical sourcing and export enquiries can be discussed with Kelar Pharmachem India, subject to product availability and confirmation.

6. Side Effects

Side effects reported with ceftizoxime include the following. The likelihood and severity may vary between patients.

Common Side Effects

• Skin rash, itching or fever.

• Diarrhoea, nausea or vomiting.

• Pain, tenderness or inflammation at the injection site.

• Temporary changes in certain liver enzyme or blood test results.

Less Common or Serious Side Effects

• Severe allergic reactions, including anaphylaxis.

• Significant or persistent diarrhoea associated with antibiotic treatment.

• Changes in blood cell counts, including anaemia or reduced white blood cells or platelets.

• Changes in kidney function.

• Rarely, serious skin reactions or seizures, particularly in susceptible patients.

Seek urgent medical attention for breathing difficulties, facial or throat swelling, severe skin reactions or other signs of a serious adverse reaction.

7. How Does It Work?

Ceftizoxime belongs to the beta-lactam group of antibiotics. It works by interfering with bacterial cell-wall synthesis, binding to penicillin-binding proteins and preventing susceptible bacteria from forming a functional cell wall. This action can lead to bacterial death. Its effectiveness depends on the susceptibility of the organism, and it does not treat viral infections.

8. Dosage Guidelines

The appropriate dose and treatment duration depend on the infection, its severity, bacterial susceptibility, the patient’s age and clinical condition, and kidney function.

• Use only the dose prescribed by a qualified healthcare professional.

• Dose adjustments may be necessary in patients with impaired renal function.

• The injection must be prepared and administered by appropriately qualified healthcare professionals.

• Follow the approved product instructions for the administration route, reconstitution, compatible diluents and use after preparation.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

9. When Not to Use

Ceftizoxime should not be used in patients with a known allergy to ceftizoxime.

• Inform the treating healthcare professional about previous reactions to cephalosporins, penicillins or other beta-lactam antibiotics.

• A history of penicillin allergy requires individual assessment; it does not automatically establish the same level of risk for every cephalosporin.

• The medicine should not be used without an appropriate clinical indication.

The final decision must follow the approved product information and the patient’s medical history.

10. Drug / Product Interactions

Potential interaction considerations for ceftizoxime include:

• Aminoglycoside antibiotics: Concurrent treatment may require careful assessment and monitoring of kidney function.

• Anticoagulants: Monitoring of blood-clotting parameters may be appropriate in patients at risk.

• Other medicines affecting kidney function: The combination should be assessed according to the medicines involved and the patient’s clinical status.

Healthcare professionals should review the current prescribing information and the patient’s medication history before treatment.

11. Safety Advice

• Use only under appropriate medical supervision.

• Check the patient’s allergy history before administration.

• Use the prescribed dose and intended administration route.

• Monitor for allergic reactions and other clinically significant adverse effects.

• Inform the treating healthcare professional about kidney problems, previous colitis or significant gastrointestinal disease.

• Use antibiotics only when indicated for bacterial infections to help reduce antimicrobial resistance.

12. General Instructions

• Verify the product name, strength, batch number and expiry date before use.

• Check that the vial and container closure are intact.

• Follow the approved preparation and administration instructions for the specific product.

• Maintain appropriate aseptic handling practices.

• Do not use a damaged or compromised container.

• Follow the specified instructions for use and handling after reconstitution.

• Dispose of unused medicine and clinical waste according to applicable procedures.

Do not assume that preparation volumes, diluents or post-reconstitution stability are the same for every injectable ceftizoxime presentation.

13. Special Dietary / Lifestyle Tips

No universal dietary restriction is established for all ceftizoxime injection presentations.

• Follow the treating healthcare professional’s instructions throughout treatment.

• Complete the prescribed course as directed.

• Do not share antibiotics with other people.

• Report persistent diarrhoea or other unexpected symptoms to a healthcare professional.

14. Comparison with Other Treatments

Ceftizoxime is one option within the cephalosporin antibiotic group. Its suitability depends on the infection and the susceptibility of the causative bacteria.

No antibiotic should be assumed to be superior to another in every situation. The selection should be guided by clinical assessment, microbiology results where available and applicable treatment guidelines.

15. Precautions & Warnings

• Allergy risk: Previous hypersensitivity to ceftizoxime or other beta-lactam antibiotics should be assessed before treatment.

• Kidney function: Patients with renal impairment may require dosage adjustment and appropriate monitoring.

• Gastrointestinal complications: Severe or persistent diarrhoea during or after treatment requires medical assessment.

• Blood-related effects: Monitoring may be necessary in patients at risk of altered blood counts or clotting parameters.

• Antimicrobial resistance: Unnecessary use can contribute to antibiotic resistance.

• Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the patient’s circumstances and applicable product information.

Serious allergic reactions require immediate medical attention.

16. Can I Use It With Other Medicines?

Ceftizoxime may be used alongside other medicines when clinically appropriate, but concurrent treatment requires professional assessment.

Inform the healthcare professional about all prescription medicines, non-prescription medicines and supplements being taken. Special attention may be needed when other antibiotics, anticoagulants or medicines affecting kidney function are involved.

Physical compatibility must also be checked before ceftizoxime is mixed with another medicine in a syringe, infusion container or administration line. Compatibility should not be assumed without product-specific evidence.

17. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage conditions before and after reconstitution may differ. Follow the verified instructions for the specific product and do not use a prepared solution beyond its approved period of use.

18. Frequently Asked Questions (FAQs)

1. What is Ceftizoxime For Injection USP used for?

It is a cephalosporin antibiotic used to treat certain susceptible bacterial infections when prescribed by a qualified healthcare professional.

2. Which active ingredient does this product contain?

The active ingredient is ceftizoxime.

3. What strengths are listed for this product?

The supplied product details list 250 Mg, 1000 Mg and 2gm. The availability and exact labelling of each strength should be confirmed with the supplier.

4. How is this dry powder injection prepared?

Preparation must follow the approved product-specific instructions, including the specified diluent, reconstitution procedure and administration method. A qualified healthcare professional should prepare and administer it.

5. Can patients with a penicillin allergy use ceftizoxime?

A history of penicillin allergy requires individual clinical assessment because cross-reactivity between beta-lactam antibiotics may occur. The medicine should be used only after the healthcare professional has assessed the patient’s allergy history.

6. What precautions are required before administration?

Check the patient’s allergy history, verify the prescribed dose and route, inspect the vial and follow the approved preparation instructions.

7. How should Ceftizoxime For Injection USP be stored?

Follow the manufacturer’s approved labelling and package insert. The exact storage requirements for this presentation have not been provided.

8. Is this product available for pharmaceutical export?

Kelar Pharmachem India can receive pharmaceutical sourcing and export enquiries. Product availability, commercial terms, documentation and destination-market requirements must be confirmed individually.